Bank of America’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-833
Closed -$197K 7164
2019
Q1
$197K Hold
833
﹤0.01% 5532
2018
Q4
$226K Sell
833
-1,417
-63% -$410K ﹤0.01% 5437
2018
Q3
$1M Sell
2,250
-4,167
-65% -$1.95M ﹤0.01% 4480
2018
Q2
$3.02M Hold
6,417
﹤0.01% 3639
2018
Q1
$3.78M Buy
+6,417
New +$3.98M ﹤0.01% 3334

Other funds holding ASMB

Bank of America's ASMB Position: Q1 2026 in Review

Bank of America increased its Assembly Biosciences (ASMB) stake by 113% in Q1 2026, buying an estimated $165K and bringing the position to 10,902 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #5148.

Bank of America first reported a position in ASMB in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.49M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Bank of America held 10,902 shares of Assembly Biosciences worth $303K as of Q1 2026.
  • Bank of America bought 5,792 Assembly Biosciences shares in Q1 2026, an estimated $165K.
  • Assembly Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5148 holding.
  • Bank of America first reported a position in Assembly Biosciences in Q2 2013 and has held it in 40 quarters since.
  • Bank of America's Assembly Biosciences position peaked at $2.49M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.